p53 is a key regulatory gene in the apoptotic pathway, and experimental data have shown that tumours containing wild type p53 respond better to anthracyclines than p53-mutant tumours (Lowe et al, 1993, 1994; Gudas et al, 1996). The gene discussed is TP53; the disease is neoplasm.